Foghorn Therapeutics's total assets for Q2 2025 were $226.24M, a decrease of -12.55% from the previous quarter. FHTX total liabilities were $302.89M for the fiscal quarter, a -5.45% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.